Where does CSIR rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CSIR ranks #6,638 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CSIR hold?

CSIR holds 50 US utility patents granted between 2015 and 2025, spanning 60 technology areas.

What is CSIR's Innovation Score?

CSIR has an Innovation Score of 52.8 out of 100 (top 10% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is CSIR's patent grant rate increasing or decreasing?

CSIR's recent grant velocity is -60% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for CSIR's patents?

CSIR's patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CSIR patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CSIR

Q: What technology areas does CSIR focus on?

CSIR's top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 9 patents. Grants appear in 60 CPC subclasses total.

USPTO PatentsView assignee record - 50 granted patents across 60 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, CSIR ranks #6,638 of 50,000 tracked US assignees by granted-patent volume, with 50 patents across 60 technology areas.

#6,638
of 50,000 US assignees by volume: Top 10%
by Innovation Score (52.8/100): 13.7
avg claims per patent: -60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6638 · Foreign Corporation #6,638 · 50 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 50 grants
UPPER-Q #6,638/50,000
PHOTO-FINISH Capstan Systems
CPC-WIDE C12N · 60 areas
INNOV-PAR 52.8/100
CLAIMS-RICH 13.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Capstan Ag Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Magna Steyr Fahrzeug… · near

53
Stress Engineering S… · near

53
THE University OF We… · near

53
CSIR · this assignee

53
Total · near

53
3D Lighting Innovati… · lowest

7

What this shows CSIR stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-WIDE, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, VEL-DROP, BOOK-FULL. Volume places it #6,638 of 50,000; Innovation Score 52.8/100 sits in the top 10% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Capstan Ag Systems, Inc. (±0 grants).

Portfolio overview

CSIR has been granted 50 US utility patents between 2015 and 2025, placing CSIR at #6,638 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 60 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.7 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, CSIR is one of the broader-portfolio assignees in the PatentsView dataset. By volume, CSIR sits between CHDI Foundation, Inc. (50 patents, rank #6,630) and Crucible Intellectual Property, Llc (50 patents, rank #6,638) - the closest US assignees by grant volume. The composite Innovation Score of 52.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 14 grants, compared with 35 in the 2015–2019 window, a -60% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. CSIR's 13.7 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 60 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

CHDI Foundation

50
Chinese Research…

50
Chipbond Technolo…

50
Coavis

50
Capstan Systems

50
Cascade

50
Coinplug

50
Crucible Intellec…

50
CSIR ◀

50

What this shows CSIR holds 50 patents at rank #6,634, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CSIR

By rank, the assignees closest to #6,634 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in CSIR's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CSIR, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (53 here).

Total Sa 53 THE University OF Western Ontario 53 Magna Steyr Fahrzeugtechnik Gmbh & Co KG 53 Stress Engineering Services, Inc. 53

Similar claim depth

Nearest assignees by average claims per patent (13.7 here).

Dupont Electronics, Inc. 13.7 avg Ali Corporation 13.7 avg Abbott Molecular Inc. 13.7 avg Duksan Neolux Co., Ltd 13.7 avg

CSIR's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 10% higher than 90% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

CSIR patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	24.0%
2016	6	12.0%
2017	8	16.0%
2018	4	8.0%
2019	5	10.0%
2020	3	6.0%
2021	2	4.0%
2022	4	8.0%
2023	1	2.0%
2024	4	8.0%
2025partial year	1	2.0%

Which technologies does CSIR patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 9

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 9

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 6

H01S - DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL 6

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 4

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 4

B22F - WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER ; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER 4

B33Y - ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING 3

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 3

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 3

H01M - PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY 3

C01P - INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS 3

C01G - COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F 3

Y02E - REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION 3

Top 15 of 60 technology areas

Where it ranks

Overall rank by patents

#6,638

of 50,000 tracked assignees

Innovation Score

52.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.